Journal of the Neurological Sciences
Volume 298, Issue 1 , Pages 106-109 , 15 November 2010

Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome

Received 25 March 2010 ,Revised 24 July 2010 ,Accepted 27 July 2010.

References 

  1. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci. 1999;19:5054–5065
  2. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA. 2000;97:11534–11539
  3. Yamanaka G, Ishii C, Kawashima H, Oana S, Miyajima T, Hoshika A. Cerebrospinal fluid diacron-reactive oxygen metabolite levels in pediatric patients with central nervous system diseases. Pediatr Neurol. 2008;39:80–84
  4. Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe F, et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia. 2006;47:1160–1168
  5. Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M, Vezzani A. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis. 2008;31:327–333
  6. Peltola J, Palmio J, Korhonen L, Suhonen J, Miettinen A, Hurme M, et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 2000;41:205–211
  7. Lehtimaki KA, Keranen T, Palmio J, Makinen R, Hurme M, Honkaniemi J, et al. Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol Scand. 2007;116:226–230
  8. Lehtimaki K, Keranen T, Huuhka M, Palmio J, Hurme M, Leinonen E, et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT. 2008;24:88–91
  9. Lehtimaki KA, Keranen T, Palmio J, Peltola J. Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures. Neuroimmunomodulation. 2010;17:19–22
  10. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis. 2006;24:128–143
  11. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008;29:142–160
  12. Liu ZS, Wang QW, Wang FL, Yang LZ. Serum cytokine levels are altered in patients with West syndrome. Brain Dev. 2001;23:548–551
  13. Montelli TC, Soares AM, Peracoli MT. Immunologic aspects of West syndrome and evidence of plasma inhibitory effects on T cell function. Arq Neuropsiquiatr. 2003;61:731–737
  14. Tekgul H, Polat M, Tosun A, Serdaroglu G, Kutukculer N, Gokben S. Cerebrospinal fluid interleukin-6 levels in patients with West syndrome. Brain Dev. 2006;28:19–23
  15. Haginoya K, Noguchi R, Zhao Y, Munakata M, Yokoyama H, Tanaka S, et al. Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome. Epilepsy Res. 2009;85:314–317
  16. Shiihara T, Miyashita M, Yoshizumi M, Watanabe M, Yamada Y, Kato M. Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome. Brain Dev 2009. Epub 2009 Dec 1.
  17. Ohya T, Nagai T, Araki Y, Yanagawa T, Tanabe T, Iyoda K, et al. A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome. Brain Dev. 2009;31:739–743
  18. Lombroso CT. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia. 1983;24:135–158
  19. Iwasaki T, Nonoda Y, Ishii M. Remission associated with human herpesvirus infection in west syndrome. J Child Neurol. 2006;21:886–890
  20. Alapirtti T, Rinta S, Hulkkonen J, Makinen R, Keranen T, Peltola J. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J Neurol Sci. 2009;280:94–97
  21. Aukrust P, Froland SS, Liabakk NB, Muller F, Nordoy I, Haug C, et al. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood. 1994;84:2136–2143
  22. Crow AR, Song S, Semple JW, Freedman J, Lazarus AH. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?. Blood. 2007;109:155–158
  23. Kovalovsky D, Pereda MP, Stalla GK, Holsboer F, Arzt E. Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and beta-endorphin. Neuroimmunomodulation. 1999;6:367–372

PII: S0022-510X(10)00341-2

doi: 10.1016/j.jns.2010.07.018

Journal of the Neurological Sciences
Volume 298, Issue 1 , Pages 106-109 , 15 November 2010

Article Tools

* Image Usage & Resolution